Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar;4(1):40-45.
doi: 10.5152/eurjrheum.2017.16052. Epub 2017 Mar 1.

Prevalence of metabolic syndrome and degree of cardiovascular disease risk in patients with Psoriatic Arthritis

Sıdıka Gülkan Özkan  1 , Hatice Yazısız  2 , Ahmet Behlül  1 , Yüksel Aslı Gökbelen  1 , Fatih Borlu  1 , Veli Yazısız  3
Affiliations

Prevalence of metabolic syndrome and degree of cardiovascular disease risk in patients with Psoriatic Arthritis

Sıdıka Gülkan Özkan et al. Eur J Rheumatol. 2017 Mar.

Erratum in

  • Erratum.
    [No authors listed] [No authors listed] Eur J Rheumatol. 2017 Dec;4(4):307. doi: 10.5152/eurjrheum.2017.17004. Epub 2017 Dec 1. Eur J Rheumatol. 2017. PMID: 29308291 Free PMC article.

Abstract

Objective: The aim of this study was to identify the prevalence of metabolic syndrome (MetS) and degree of cardiovascular disease (CVD) risk in patients with psoriatic arthritis (PsA).

Material and methods: We performed a cross-sectional study on 102 adult patients with PsA and a control group of 102 patients with rheumatoid arthritis (RA). MetS was diagnosed according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) and International Diabetes Federation (IDF) criteria. The Framingham risk scores of 10-year risk of CVDs and coronary heart disease (CHD) were also calculated.

Results: The prevalence of MetS was higher in patients with PsA than in those with RA, according to the NCEP-ATP III (40.6% vs. 24.7%, respectively; p=0.019) and IDF (46.8% vs. 27.9%, respectively; p=0.05) criteria. The prevalence of MetS was higher in female patients with PsA (p=0.009) than in male patients. A significantly increased prevalence of hypertriglyceridemia was determined in patients with PsA (p=0.019). No significant difference existed between the two groups with respect to 10-year CVD (p=0.333) and CHD (p=0.798) risks. Additionally, there were no significant differences between the clinical subtypes of PsA with regard to MetS (p=0.229).

Conclusion: MetS prevalence increased in patients with PsA compared with those with RA, whereas the risks were similar for CVDs and CHD. For this reason, optimal protection measures should be taken and guidelines should be applied to achieve adequate metabolic control in patients with PsA.

Keywords: Psoriatic arthritis; cardiovascular disease; coronary heart disease; metabolic syndrome; rheumatoid arthritis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: No conflict of interest was declared by the authors.

References

    1. Gelfand JM1, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol. 2005;53:573–7. - PubMed
    1. Leczinsky CG. The incidence of arthropathy in a ten-year series of psoriasis cases. Acta Derm Venereol. 1948;28:483–7. - PubMed
    1. Reich K, Krüger K, Mössner R, Augustin M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol. 2009;160:1040–7. https://doi.org/10.1111/j.1365-2133.2008.09023.x. - DOI - PubMed
    1. Gladman DD. Psoriatic arthritis. In: Klippel JH, Stone JH, Crofford LJ, White PH, editors. Primer on the Rheumatic Diseases. Springer; New York: USA: 2008. pp. 170–193. https://doi.org/10.1007/978-0-387-68566-3_8. - DOI
    1. Cakır N, Pamuk ÖN, Derviş E, Imeryüz N, Uslu H, Benian Ö, et al. The prevalences of some rheumatic disease in western Turkey: Havsa study. Rheumatol Int. 2012;32:895–908. https://doi.org/10.1007/s00296-010-1699-4. - DOI - PubMed